Calling all healthtech founders: Your data strategy can make or break a deal

Private equity and venture capital interest in healthtech has surged and activity shows no sign of abating this year.

But some investors are learning the hard way that a glossy pitch deck and polished paperwork are not enough to secure funding, especially when a company’s value hinges on access to sensitive health data, such as biometric scans, genetic profiles, mental health logs and daily activity tracking.